1-67219704-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_144701.3(IL23R):c.929T>C(p.Leu310Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.877 in 1,613,024 control chromosomes in the GnomAD database, including 621,497 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. L310L) has been classified as Likely benign.
Frequency
Consequence
NM_144701.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL23R | NM_144701.3 | c.929T>C | p.Leu310Pro | missense_variant | 7/11 | ENST00000347310.10 | NP_653302.2 | |
IL23R | XM_011540790.4 | c.929T>C | p.Leu310Pro | missense_variant | 7/11 | XP_011539092.1 | ||
IL23R | XM_011540791.4 | c.929T>C | p.Leu310Pro | missense_variant | 7/11 | XP_011539093.1 | ||
IL23R | XM_047447227.1 | c.929T>C | p.Leu310Pro | missense_variant | 7/11 | XP_047303183.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.848 AC: 128970AN: 152018Hom.: 54990 Cov.: 31
GnomAD3 exomes AF: 0.883 AC: 221943AN: 251350Hom.: 98314 AF XY: 0.886 AC XY: 120288AN XY: 135838
GnomAD4 exome AF: 0.880 AC: 1285433AN: 1460888Hom.: 566471 Cov.: 46 AF XY: 0.881 AC XY: 640508AN XY: 726824
GnomAD4 genome AF: 0.848 AC: 129061AN: 152136Hom.: 55026 Cov.: 31 AF XY: 0.850 AC XY: 63210AN XY: 74340
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 03, 2025 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied by a panel of primary immunodeficiencies. Number of patients: 88. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at